S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|ISIS Pharmaceuticals' and Biogen idec's innovative collaboration voted breakthrough alliance of 2014|
|Isis Reports Updated Results from ISIS-SMN Rx Clinical Studies in Infants and Children with Spinal Muscular Atrophy (2014/4/29)|
|Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx in the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery|
|Isis Pharmaceuticals Reports Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c in Patients With Type 2 Diabetes|
|Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With Familial Chylomicronemia|
|Webcast Alert: Isis Pharmaceuticals' First Quarter 2014 Financial Results Conference Call|
|Isis Pharmaceuticals Earns $3.0 Million from GSK|
|Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-PKK Rx|
|Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at the 2014 AAN Annual Meeting (2014/4/22)|
|Isis Pharmaceuticals to Present at the Deutsche Bank 39th Annual Health Care Conference|
Click above to view more mutual fund data and stats for isis - Isis Pharmaceuticals.